Stabilization of activation induced cytidine deaminase by bortezomib does not confer increased drug target mutation frequency

Holly A.F. Stessman, Aatif Mansoor, Michael A. Linden, Brian Van Ness, Linda B. Baughn

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)220-222
Number of pages3
JournalLeukemia and Lymphoma
Issue number1
StatePublished - Jan 1 2014

Cite this